DURECT Inks Co-marketing And Collaboration Deal With Charles River For ALZET Product Line
(RTTNews) - Biopharmaceutical company DURECT Corp. (DRRX) announced Monday that it has entered into a co-marketing and collaboration agreement with Charles River Laboratories International, Inc. (CRL) for the ALZET Osmotic Pumps Portfolio and Associated Product Line in the U.S. and Canada.
Charles River Research Models & Services (RMS) sales and marketing teams will collaborate with DURECT to jointly market and commercialize the ALZET product line to existing and new customers over a multi-year period.
Charles River RMS will provide dedicated marketing resources and collaborate with DURECT to develop and roll out a broad range of sales and marketing initiatives for ALZET.
DURECT will remain responsible for manufacturing, marketing support, order fulfillment and customer billing.
Charles River Laboratories Slashes FY24 Outlook - Update
Charles River Laboratories Reaffirms FY24 Outlook; Q1 Results Top Estimates
Charles River Laboratories Narrows FY23 Outlook Range; Q3 Results Top Estimates
Charles River Labs Boosts FY23 Outlook As Q2 Results Top Estimates
Charles River Labs Slashes FY22 Outlook; Q2 Adj. EPS Tops Estimates, Revenues Miss
DURECT Appoints Timothy Papp As New CFO
Canadian Stocks Turning In Mixed Performance; TSX Down Marginally
